Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Change in Account Payables (2022 - 2025)

Historic Change in Account Payables for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to $1.0 million.

  • Envoy Medical's Change in Account Payables rose 49880.95% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $751000.0, marking a year-over-year increase of 12313.62%. This contributed to the annual value of -$19000.0 for FY2024, which is 10344.83% down from last year.
  • Per Envoy Medical's latest filing, its Change in Account Payables stood at $1.0 million for Q3 2025, which was up 49880.95% from -$43000.0 recorded in Q2 2025.
  • Envoy Medical's Change in Account Payables' 5-year high stood at $2.6 million during Q3 2023, with a 5-year trough of -$3.4 million in Q4 2023.
  • For the 4-year period, Envoy Medical's Change in Account Payables averaged around $123133.3, with its median value being $168000.0 (2024).
  • Over the last 5 years, Envoy Medical's Change in Account Payables had its largest YoY gain of 243504.99% in 2023, and its largest YoY loss of 69159.52% in 2023.
  • Over the past 4 years, Envoy Medical's Change in Account Payables (Quarter) stood at $583000.0 in 2022, then tumbled by 691.6% to -$3.4 million in 2023, then skyrocketed by 93.56% to -$222000.0 in 2024, then skyrocketed by 553.15% to $1.0 million in 2025.
  • Its Change in Account Payables stands at $1.0 million for Q3 2025, versus -$43000.0 for Q2 2025 and $10000.0 for Q1 2025.